Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments.
about
Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate ModelsRectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized miceVaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus MacaquesSurrogates of protection in repeated low-dose challenge experiments.Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys.Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.The role of exposure history on HIV acquisition: insights from repeated low-dose challenge studies.Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen.Analysis of repeated low-dose challenge studies.Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysSIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses.Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaA trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challengeShort Communication: Practical Experience with Analysis and Design of Repeat Low-Dose SHIVSF162P3 Exposure Studies in Female Pigtail Macaques with Varying Susceptibility During Menstrual Cycling.A discrete-time survival model with random effects for designing and analyzing repeated low-dose challenge experiments.Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus VaccineImmune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.Estimating the per-exposure effect of infectious disease interventions.Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.Assessment of mucosal immunity to HIV-1.Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.A method to address between-subject heterogeneity for identification of principal surrogate markers in repeated low-dose challenge HIV vaccine studies.Non-human primate models of hormonal contraception and HIV.Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques.
P2860
Q27318212-BFA2CBC7-55A9-4FC0-9658-9DA5D6CCFED7Q28488527-741E9623-C49B-459C-BC4B-8FCADED57E65Q28830298-F457B703-F4F0-4403-86E8-634EA1F2CC9FQ30371157-A775115D-73F9-4DF0-8B30-E0E5FD0530E4Q33780980-5E533F33-E54E-492E-B6BB-9B5B3772180DQ34198191-07A03801-9268-48E1-A181-8E95D76C6556Q34488291-D1B56452-0123-41F0-B9FC-789D0DA9FF2CQ35192726-C26B69E2-0E38-41F5-AD24-D516FE99E497Q35572202-9E2448C3-D647-4903-B776-B33D08AB431FQ35729899-BF8A3EB9-1626-408D-B830-999B5BE4049CQ35754196-EBDE860E-7326-4D36-9EC7-83BD2A45BAF7Q35826525-254AF6C4-D079-494E-8AEB-7F7852C81811Q36024470-905457DB-28FB-470B-B7EA-0BDFBED4E9BFQ36259499-F1E190EF-C09C-4E41-B845-C399F15254EBQ36674455-E2904ADF-26B3-47A2-8003-AE7899A70CDFQ36708266-956F6C19-86BC-451E-867A-5450FB728F82Q37032170-032957F0-1AD2-458E-8834-607FE0C0C83EQ37355237-4B6E0BBF-CE91-45B6-A8A4-6DC0F207E8B0Q37503103-37954344-79A3-401F-87A6-E5FEF93CE493Q37625296-254B1570-65F1-4244-A083-768B82E4FEC1Q37724856-02DBB812-D0F6-477B-BEAB-E24EA25B7028Q39726192-A2CEECFB-A025-4267-A511-6A15BA860E4BQ40101835-7B687BF1-7625-4BB1-8DE8-7E01C7663757Q42225882-5068BFB7-C887-4332-9992-01E0A8D1DAD8Q47550072-EDADC591-0CC4-49D6-96F9-A9A673A842F0
P2860
Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Power to detect the effects of ...... ow-dose challenge experiments.
@en
Power to detect the effects of ...... ow-dose challenge experiments.
@nl
type
label
Power to detect the effects of ...... ow-dose challenge experiments.
@en
Power to detect the effects of ...... ow-dose challenge experiments.
@nl
prefLabel
Power to detect the effects of ...... ow-dose challenge experiments.
@en
Power to detect the effects of ...... ow-dose challenge experiments.
@nl
P2093
P2860
P356
P1476
Power to detect the effects of ...... ow-dose challenge experiments.
@en
P2093
Chih-Da Wu
Dan H Barouch
Michael G Hudgens
Peter B Gilbert
Steven G Self
P2860
P304
P356
10.1086/600891
P407
P577
2009-08-01T00:00:00Z